Vulnerable Plaque Imaging Will Pave Way For MI Prevention Therapy – Stone
This article was originally published in The Gray Sheet
Executive Summary
A proven vulnerable plaque (VP) treatment will not be a reality for at least another five to ten years, due to the complexity of VP detection, according to Gregg Stone, MD, Columbia University
You may also be interested in...
Volcano Ready To Erupt? Vascular Imaging Start-Up Lures Big-Time Partners
Ultrasound catheter firm Volcano Corp. only went public in June, but it has already attracted noticeable interest from the top players in the device industry
Volcano Ready To Erupt? Vascular Imaging Start-Up Lures Big-Time Partners
Ultrasound catheter firm Volcano Corp. only went public in June, but it has already attracted noticeable interest from the top players in the device industry
Vulnerable Plaque, CABG Patients Would Expand Stent Candidate Pool
Interventional cardiology device makers are developing new patient populations now that drug-eluting stents are shown to virtually eliminate restenosis